Literature DB >> 4595633

Pharmacokinetics of cloxacillin in patients on chronic intermittent haemodialysis and in healthy subjects.

E H Nauta, H Mattie, W R Goslings.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4595633     DOI: 10.1159/000221464

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  11 in total

1.  Effect of probenecid on the apparent volume of distribution and elimination of cloxacillin.

Authors:  E H Nauta; H Mattie; W R Goslings
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

Review 2.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

3.  The passage of cloxacillin into cerebrospinal fluid in the absence of meningitis.

Authors:  H I Schievink; H Mattie; R T Thomeer; E Van Strijen
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

4.  Mecillinam in patients on haemodialysis.

Authors:  K Bailey; J G Cruickshank; P G Bisson; B L Radford
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

5.  Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.

Authors:  E H Nauta; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

7.  The metabolic disposition of flucloxacillin in patients with impaired kidney function.

Authors:  H H Thijssen; J Wolters
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

Review 9.  Plasma protein binding of digitoxin and some other drugs in renal disease.

Authors:  J J Lohman; F W Merkus
Journal:  Pharm Weekbl Sci       Date:  1987-04-24

10.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.